The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

The synthetic additive found in thousands of food products will now be phased out by 2027, but advocates say the agency's ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

Houston-area candy manufactures react to the U.S. Food and Drug Administration's ban on red dye linked to cancer.

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

Here are some of the products that won't be able to sell without removing Red dye No. 3 following the FDA's recent ban ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Red Dye No. 3, also known as erythrosine, is a synthetic food dye that gives foods and drinks a bright red color. It is also ...

Soon enough, American grocery stores will be free of red dye 3. On January 15, the Food and Drug Administration (FDA) ...

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.

Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.